These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9664517)

  • 21. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2000 Apr; 163(4):1183-8. PubMed ID: 10737491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells.
    McIntyre IG; Spreckley K; Clarke RB; Anderson E; Clarke NW; George NJ
    Br J Cancer; 2000 Oct; 83(8):992-7. PubMed ID: 10993644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability of PSA circulating cells as markers of metastatic prostate cancer.
    Cardillo MR; Di Silverio F; Gentile V
    Scand J Clin Lab Invest; 2004; 64(7):687-89. PubMed ID: 15513326
    [No Abstract]   [Full Text] [Related]  

  • 24. [Detection of circulating prostatic cells with RT-PCR PSA in prostatic cancer].
    de la Taille A; Salomon L; Colombel M; Abbou CC; Chopin D; Groux-Muscatelli B
    Prog Urol; 1999 Dec; 9(6):1084-9. PubMed ID: 10658255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative PSA RT-PCR for preoperative staging of prostate cancer.
    Kurek R; Ylikoski A; Renneberg H; Konrad L; Aumüller G; Roddiger SJ; Zamboglou N; Tunn UW; Lilja H
    Prostate; 2003 Sep; 56(4):263-9. PubMed ID: 12858354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction.
    Fadlon EJ; Rees RC; McIntyre C; Sharrard RM; Lawry J; Hamdy FC
    Br J Cancer; 1996 Aug; 74(3):400-5. PubMed ID: 8695355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the RNA-amplification based methods RT-PCR and NASBA for the detection of circulating tumour cells.
    Burchill SA; Perebolte L; Johnston C; Top B; Selby P
    Br J Cancer; 2002 Jan; 86(1):102-9. PubMed ID: 11857020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells.
    Zippelius A; Lutterbüse R; Riethmüller G; Pantel K
    Clin Cancer Res; 2000 Jul; 6(7):2741-50. PubMed ID: 10914719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy.
    Ross RW; Manola J; Hennessy K; Galsky M; Scher H; Small E; Kelly WK; Kantoff PW
    Clin Cancer Res; 2005 Jul; 11(14):5195-8. PubMed ID: 16033836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detecting prostate cancer by intracellular macrophage prostate-specific antigen (PSA): a more specific and sensitive marker than conventional serum total PSA.
    Herwig R; Mitteregger D; Djavan B; Kramer G; Margreiter M; Leers MP; Glodny B; Haider DG; Hörl WH; Marberger M
    Eur J Clin Invest; 2008 Jun; 38(6):430-7. PubMed ID: 18489403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships between reverse transcriptase-polymerase chain reaction for prostate specific antigen, survival, and various prognostic laboratory factors in patients with hormone refractory prostate cancer.
    Gandhok NK; Looney S; Koochekpour S; Sartor O
    Urol Oncol; 2005; 23(3):163-7. PubMed ID: 15907715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of detecting circulating cancer cells in patients with solid malignancies].
    Majima T; Ichikura T; Mochizuki H
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):769-75. PubMed ID: 11432343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative real-time RT-PCR assay for PCA3.
    Väänänen RM; Rissanen M; Kauko O; Junnila S; Väisänen V; Nurmi J; Alanen K; Nurmi M; Pettersson K
    Clin Biochem; 2008 Jan; 41(1-2):103-8. PubMed ID: 17996198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancer.
    Garcia JA; Rosenberg JE; Weinberg V; Scott J; Frohlich M; Park JW; Small EJ
    BJU Int; 2007 Mar; 99(3):519-24. PubMed ID: 17407512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of urine DD3/PSA mRNA ratio by duplex TaqMan RT-PCR assay and evolution of its primary application].
    Chen FP; Chen LL; Shen M; Chen W; Tao ZH; Wu XL; Hu YP; Li CD; Chen ZG; Chen XD
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):261-4. PubMed ID: 18361839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative PSA mRNA determination in blood: a biochemical tool for scoring localized prostate cancer.
    Zambon CF; Basso D; Prayer-Galetti T; Navaglia F; Fasolo M; Fogar P; Greco E; Pagano F; Plebani M
    Clin Biochem; 2006 Apr; 39(4):333-8. PubMed ID: 16516186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The PSA gene: value in detection of circulating prostate cancer cells].
    de la Taille A; Colombel M; Amsellem S; Muscatelli B; Radvanyi F; Mazeman E; Abbou CC; Chopin D
    Prog Urol; 1997 Dec; 7(6):930-6. PubMed ID: 9490137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ability of PSA-positive circulating macrophages to detect prostate cancer.
    Herwig R; Horninger W; Rehder P; Klocker H; Ramoner R; Thurnher M; Pinggera GM; Gozzi C; Konwalinka G; Bartsch G
    Prostate; 2005 Feb; 62(3):290-8. PubMed ID: 15389786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and molecular followup after radical retropubic prostatectomy.
    Oefelein MG; Ignatoff JM; Clemens JQ; Watkin W; Kaul KL
    J Urol; 1999 Aug; 162(2):307-10; discussion 310-1. PubMed ID: 10411026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.